202 related articles for article (PubMed ID: 33178381)
1. Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study.
Sharma S; Agarwal S
J Clin Aesthet Dermatol; 2020 Aug; 13(8):40-44. PubMed ID: 33178381
[No Abstract] [Full Text] [Related]
2. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
3. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
Nofal A; Alakad R
J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Intralesional
Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
[TBL] [Abstract][Full Text] [Related]
5. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
7. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
Vania R; Pranata R; Tan ST
J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
[TBL] [Abstract][Full Text] [Related]
8. A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine.
Achdiat PA; Yunitasari ; Usman HA; Maharani RH
Int Med Case Rep J; 2023; 16():739-746. PubMed ID: 38020581
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine.
Kansal NK
Dermatol Ther; 2020 Nov; 33(6):e13987. PubMed ID: 32638481
[TBL] [Abstract][Full Text] [Related]
10. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
Rageh RM; Hewedy ES; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
[TBL] [Abstract][Full Text] [Related]
11. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
12. A Study to Evaluate the Role of Intradermal and Intralesional Measles, Mumps, Rubella (MMR) Vaccine in Treatment of Common Warts.
Gupta P; Tegta GR; Verma GK; Gupta A; Gupta M; Sharma S
Indian Dermatol Online J; 2020; 11(4):559-565. PubMed ID: 32832442
[TBL] [Abstract][Full Text] [Related]
13. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.
Awal G; Kaur S
J Clin Aesthet Dermatol; 2018 May; 11(5):15-20. PubMed ID: 29785233
[No Abstract] [Full Text] [Related]
16. A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine.
Singh AK; Devi KN; Bist JS
Dermatol Ther; 2022 Nov; 35(11):e15813. PubMed ID: 36088627
[TBL] [Abstract][Full Text] [Related]
17. Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature.
Al-Qassabi AM; Al-Farsi F
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):413-416. PubMed ID: 36072081
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Efficacy of Intralesional Purified Protein Derivative (PPD) Versus Intralesional Measles, Mumps, and Rubella (MMR) Vaccine in Management of Multiple Viral Warts.
Bhalala KB; Poojary S; Shah KS
J Cutan Aesthet Surg; 2021; 14(4):397-403. PubMed ID: 35283602
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of autoimplantation therapy and intralesional injection of MMR vaccine in warts treatment.
ElGhareeb MI
Dermatol Ther; 2019 Nov; 32(6):e13135. PubMed ID: 31648401
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinical study of the efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts.
Shaldoum DR; Hassan GFR; El Maadawy EH; El-Maghraby GM
J Cosmet Dermatol; 2020 Aug; 19(8):2033-2040. PubMed ID: 31925891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
